Transforaminal and Parasagittal Approach in Lumbar Epidural Steroid Injection

Sponsor
Diskapi Teaching and Research Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05551676
Collaborator
(none)
60
1
2
18
3.3

Study Details

Study Description

Brief Summary

Lumbar epidural injection is used in the treatment of lumbar radicular pain. There are three different application methods: lateral parasagittal, midline interlaminar and transforaminal epidural injection. Investigator aimed to compare lateral parasagittal and transforaminal epidural injection methods. The purpose of the study is to determine which method is more efficient.

Condition or Disease Intervention/Treatment Phase
  • Procedure: transforaminal group
  • Procedure: Lateral parasagittal group
N/A

Detailed Description

It was planned to recruit 60 participants in the study. Interlaminar epidural steroid injection will be applied to 30 patients with midline and 30 patients with lateral parasagittal approach. All patients will receive Oswestry disability index before and 2-4-12 weeks after the procedure. All patients will receive Somatization Amplification Scale (SSAS) before the treatment. The results of the patients will be compared. It will be investigated which method is more effective.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison of Lateral Parasagittal Approach and Transforaminal Epidural Approach in Lumbar Epidural Steroid Injection
Actual Study Start Date :
Jun 22, 2022
Anticipated Primary Completion Date :
Jun 22, 2023
Anticipated Study Completion Date :
Dec 22, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Transforaminal group

Transforaminal steroid injection will be applied, 30 patients

Procedure: transforaminal group
Epidural steroid injection will be applied with transforaminal approach accompanied by fluoroscopy.

Active Comparator: Lateral parasagittal group

Lateral parasagittal steroid injection will be applied, 30 patients

Procedure: Lateral parasagittal group
Epidural steroid injection will be applied with lateral parasagittal approach accompanied by scopy.

Outcome Measures

Primary Outcome Measures

  1. Oswestry disability index [baseline, week 4, week 12]

    Oswestry Low Back Pain Disability Questionnaire, the Oswestry Disability Index helps to measure a patient's lower back pain. It evaluates the extent to which the patient's level of function is restricted by the pain, concentrating on the effects rather than the nature of the pain. 0% to 20%: minimal disability 41%-60%: severe disability 61%-80%: crippled

Other Outcome Measures

  1. The SomatoSensory Amplification Scale [Baseline]

    a 10-item self-report instrument designed to assess the tendency to detect somatic and visceral sensations and experience them as unusually intense, toxic and alarming. 10: No symptom, 50: worst symptoms

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Unilateral low back pain, radiculopathy
Exclusion Criteria:
  • malignancy

  • past back surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Diskapi Yildirim Beyazıt Teaching and Research Hospital Ankara Turkey

Sponsors and Collaborators

  • Diskapi Teaching and Research Hospital

Investigators

  • Study Director: Ömer Taylan AKKAYA, Diskapi TRH
  • Study Chair: Hüseyin Alp Alptekin, Diskapi TRH
  • Principal Investigator: Ezgi Can, Diskapi TRH

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Damla Yürük, Director, Diskapi Teaching and Research Hospital
ClinicalTrials.gov Identifier:
NCT05551676
Other Study ID Numbers:
  • Lomber Epidural
First Posted:
Sep 23, 2022
Last Update Posted:
Sep 23, 2022
Last Verified:
Sep 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Damla Yürük, Director, Diskapi Teaching and Research Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 23, 2022